Univest
Univest
  • Markets

Amrutanjan Health Care Q2 Results FY27: PAT Jumps 23.78% to Rs 17.28 Cr, Revenue Rs 135.18 Cr

  • November 4, 2026
  • Posted by: Harsh Piplani
  • Category: Results
No Comments
Amrutanjan Health Care Q2 Results FY27: PAT Jumps 23.78% to Rs 17.28 Cr, Revenue Rs 135.18 Cr

Quick Answer

Amrutanjan Health Care Q2 Results FY27 were declared on 3 November 2026 on a standalone basis. Revenue came in at Rs 135.18 Cr, a YoY growth of 14.85 percent from Rs 117.70 Cr. Net profit rose 23.78 percent to Rs 17.28 Cr from Rs 13.96 Cr. These quarterly results cover July to September 2026.

Amrutanjan Health Care Ltd (AMRUTANJAN) Q2 Results FY27 announced on 3 November 2026, covering the company’s financial performance for the July to September quarter. The company reported revenue of Rs 135.18 Cr and PAT of Rs 17.28 Cr. Amrutanjan Health Care Q2 Results FY27 set out the full picture for the quarter. The results date of 3 November 2026 and the standalone results basis frame every figure below.

This Amrutanjan Health Care Q2 Results results analysis covers the financial highlights, the business factors, the outlook and the risks, and it starts with the Financial Highlights table. Univest readers can use the Univest Screener to compare these figures with other listed companies.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • Amrutanjan Health Care Q2 Results FY27: Financial Highlights
  • Key Takeaways from Amrutanjan Health Care Q2 Results: What Stands Out
  • Amrutanjan Health Care Q2 Results FY27: Performance Analysis
  • Key Business Factors This Quarter
  • FY27 Outlook After Amrutanjan Health Care Q2 Results
  • Key Risks to Watch After Amrutanjan Health Care Q2 Results FY27
    • Volatile Quarterly Net Profit
    • Lower Annual Earnings Since FY22
    • Quarter Versus Long-Term Trend
  • Conclusion
  • Frequently Asked Questions on Amrutanjan Health Care Q2 Results FY27
    • What are Amrutanjan Health Care Q2 Results FY27?
    • What is the results date for Amrutanjan Health Care Q2 Results FY27?
    • What revenue was reported in Amrutanjan Health Care Q2 Results FY27?
    • What net profit was reported in Amrutanjan Health Care Q2 Results FY27?
    • How much YoY growth did revenue show in Amrutanjan Health Care Q2 Results FY27?
    • Did net profit rise or fall in Amrutanjan Health Care Q2 Results?
    • What was the Operating Profit in Amrutanjan Health Care Q2 Results FY27?
    • Are Amrutanjan Health Care Q2 Results standalone results?
    • What business factors shaped Amrutanjan Health Care Q2 Results FY27?
    • What are the key risks after Amrutanjan Health Care Q2 Results FY27?
    • What is the outlook after Amrutanjan Health Care Q2 Results?
    • Where can I find the complete Amrutanjan Health Care Q2 Results FY27 data?

Amrutanjan Health Care Q2 Results FY27: Financial Highlights

Metric Q2 FY27 (Sep 26) Q2 FY26 (Sep 25) YoY Change
Revenue Rs 135.18 Cr Rs 117.7 Cr +14.85% YoY
Operating Profit Rs 23.61 Cr Rs 16.53 Cr +42.83% YoY
Net Profit (PAT) Rs 17.28 Cr Rs 13.96 Cr +23.78% YoY

Source: company filing for Amrutanjan Health Care Q2 Results FY27, 3 November 2026. Figures in Rs Crore, Standalone basis.

Key Takeaways from Amrutanjan Health Care Q2 Results: What Stands Out

  • Revenue of Rs 135.18 Cr rose 14.85 percent from Rs 117.70 Cr in the same quarter of last year.
  • Net profit of Rs 17.28 Cr compares with Rs 13.96 Cr a year ago, a YoY growth of 23.78 percent.
  • Operating Profit of Rs 23.61 Cr rose 42.83 percent from Rs 16.53 Cr in the same quarter of last year.
  • Return on capital employed of 22.46 percent in FY26 sits beside the quarter’s growth, as Amrutanjan Health Care Q2 Results FY27 show.
  • Return on equity of 16.62 percent in FY26 sits alongside flagged risks, and the performance analysis now takes up these numbers.

Amrutanjan Health Care Q2 Results FY27: Performance Analysis

Amrutanjan Health Care reported standalone revenue of Rs 135.18 Cr, against Rs 117.70 Cr a year earlier, while net profit moved from Rs 13.96 Cr to Rs 17.28 Cr. On a YoY basis revenue rose 14.85 percent and net profit rose 23.78 percent. Revenue, Operating Profit and net profit each moved as the Financial Highlights table shows, and every figure there matches the numbers quoted in this section.

Operating Profit rose 42.83 percent to Rs 23.61 Cr from Rs 16.53 Cr. In Amrutanjan Health Care Q2 Results FY27, Operating Profit grew faster than both net profit and revenue, so the operating line led the quarter’s gains. The Operating Profit line and the net profit line are best read together, since each is reported as supplied in the filing, and this results analysis uses only those supplied figures.

The Amrutanjan Health Care Q2 Results data confirms what changed in the quarterly results but does not establish the specific cause, so the next step is to read the disclosed drivers. Investors can track later disclosures to see how the YoY growth builds across FY27, which is where the results analysis turns to the business factors.

Check the Univest Screener for live results data

Key Business Factors This Quarter

Revenue Growth – The results analysis points to revenue growth of 14.9 percent year on year to Rs 135.18 Cr in the latest quarter, and it is the first factor listed for Amrutanjan Health Care Q2 Results FY27.

Net Profit Growth – Net profit rose 23.8 percent year on year to Rs 17.28 Cr, which is why net profit sits beside revenue as the lead disclosure for this quarter.

Returns on Equity and Capital – Return on equity was 16.62 percent in FY26 and return on capital employed was 22.46 percent in FY26, as supplied for this standalone filing.

FY27 Outlook After Amrutanjan Health Care Q2 Results

No explicit management guidance is supplied with these results, so the FY27 view rests on the numbers already reported. A quarter with revenue of Rs 135.18 Cr and net profit of Rs 17.28 Cr is one input into the full year, and the other quarters will complete it. Readers can follow later quarters through the Univest app, which lists results as companies declare them.

Full-year FY27 results will depend on subsequent quarters and on disclosed sector conditions. The Amrutanjan Health Care Q2 Results FY27 results analysis suggests readers watch how net profit moves against the range seen over the last five quarters, which is where the outlook hands over to the risks.

Key Risks to Watch After Amrutanjan Health Care Q2 Results FY27

Volatile Quarterly Net Profit

Quarterly net profit has been volatile, ranging from Rs 4.37 Cr to Rs 19.45 Cr over the last 5 quarters. The latest quarter of Rs 17.28 Cr sits in the upper part of that range.

Lower Annual Earnings Since FY22

Annual earnings were lower in FY26 than in FY22 in the supplied data, falling about 3.4 percent a year over the period. This long-term trend is separate from the quarter, and later disclosures will show how it develops.

Quarter Versus Long-Term Trend

The YoY net profit growth of 23.8 percent in this quarter contrasts with the lower annual earnings since FY22. Investors tracking Amrutanjan Health Care Q2 Results FY27 can see later quarters will show whether the improvement lasts.

Download the Univest iOS App or Univest Android App to track quarterly results as they are declared.

Conclusion

Amrutanjan Health Care Q2 Results FY27 show standalone revenue of Rs 135.18 Cr and net profit of Rs 17.28 Cr, with the quarterly results marking a YoY revenue change of 14.85 percent. The standalone results also list return and volatility risks. This Amrutanjan Health Care Q2 Results summary is not advice, and investors should consult a SEBI-registered advisor before acting.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.

Frequently Asked Questions on Amrutanjan Health Care Q2 Results FY27

What are Amrutanjan Health Care Q2 Results FY27?

Ans. Amrutanjan Health Care Q2 Results FY27 are the standalone quarterly results for July to September 2026, with revenue of Rs 135.18 Cr and net profit of Rs 17.28 Cr, so the Financial Highlights section carries the full comparison.

What is the results date for Amrutanjan Health Care Q2 Results FY27?

Ans. Amrutanjan Health Care Q2 Results FY27 were declared on 3 November 2026, which is the results date for the July to September 2026 quarter, and the Quick Answer box above states the same date for reference.

What revenue was reported in Amrutanjan Health Care Q2 Results FY27?

Ans. Amrutanjan Health Care reported revenue of Rs 135.18 Cr, compared with Rs 117.70 Cr a year earlier, which means revenue stands as the headline line in the Performance Analysis section.

What net profit was reported in Amrutanjan Health Care Q2 Results FY27?

Ans. Amrutanjan Health Care reported net profit of Rs 17.28 Cr in the quarter, compared with Rs 13.96 Cr a year earlier, so the Key Takeaways section treats it as a central figure.

How much YoY growth did revenue show in Amrutanjan Health Care Q2 Results FY27?

Ans. Revenue showed YoY growth of 14.85 percent in the quarter, alongside a net profit increase of 23.78 percent, as the Performance Analysis section sets out when comparing the two lines.

Did net profit rise or fall in Amrutanjan Health Care Q2 Results?

Ans. Amrutanjan Health Care net profit rose from Rs 13.96 Cr to Rs 17.28 Cr, a change of 23.78 percent, which means the Key Takeaways section lists it among the main profit lines.

What was the Operating Profit in Amrutanjan Health Care Q2 Results FY27?

Ans. Operating Profit stood at Rs 23.61 Cr against Rs 16.53 Cr a year earlier, a change of 42.83 percent, as the Financial Highlights table shows alongside revenue and net profit.

Are Amrutanjan Health Care Q2 Results standalone results?

Ans. The figures are standalone results, so they follow the standalone basis stated in the filing, while the Quick Answer box and the Conclusion both name this basis for the quarter.

What business factors shaped Amrutanjan Health Care Q2 Results FY27?

Ans. The supplied factors are revenue growth of 14.9 percent, net profit growth of 23.8 percent and returns of 16.62 percent on equity and 22.46 percent on capital employed in FY26, as the Key Business Factors section explains.

What are the key risks after Amrutanjan Health Care Q2 Results FY27?

Ans. The risks listed are volatile quarterly net profit, lower annual earnings since FY22 and a contrast between this quarter and the long-term trend, as the Key Risks section covers.

What is the outlook after Amrutanjan Health Care Q2 Results?

Ans. The FY27 outlook depends on the coming quarters, since full-year results will be built from them, while the FY27 Outlook section explains what the supplied figures can and cannot show.

Where can I find the complete Amrutanjan Health Care Q2 Results FY27 data?

Ans. The Financial Highlights table in this article lists revenue, Operating Profit and net profit with YoY changes, while the Univest Screener lets readers compare these figures with other listed companies.




Author: Harsh Piplani
I am Harsh Piplani, an Assistant Content Manager with over 5 years of experience in crafting impactful, result-driven content. I hold a B.Com (Hons) degree and have worked across diverse industries, including education, fintech, healthcare, jewellery, and more. I specialise in content strategy, SEO, and optimisation, ensuring that every piece I create is not just well-written but also well-ranked. I believe content should do more than fill space so as to drive traffic, build authority, and support business growth. I enjoy turning complex ideas into clear, engaging narratives, and, as I like to say, I know how to spin words like a web to influence, structured, strategic, and impossible to ignore. For me, great content sits at the intersection of creativity and performance.

Leave a Reply Cancel reply